{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:06:04Z","timestamp":1791417964144,"version":"4.3.3"},"reference-count":20,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Context: Hyperostosis-hyperphosphatemia syndrome (HHS) is a rare metabolic disorder characterized by hyperphosphatemia and localized hyperostosis. HHS is caused by mutations in GALNT3, which encodes UDP-N-acetyl-\u03b1-d-galactosamine:polypeptide N- acetylgalactosaminyltransferase 3. Familial tumoral calcinosis (TC), characterized by ectopic calcifications and hyperphosphatemia, is caused by mutations in the GALNT3 or fibroblast growth factor 23 (FGF23) genes.<\/jats:p>\n               <jats:p>Objective: Our objective was to identify mutations in FGF23 or GALNT3 and determine serum FGF23 levels in an HHS patient.<\/jats:p>\n               <jats:p>Design: Mutation detection in FGF23 and GALNT3 was performed by DNA sequencing, and serum FGF23 concentrations were measured by ELISA.<\/jats:p>\n               <jats:p>Patients or Other Participants: A 5-year-old French boy with HHS and his family members participated.<\/jats:p>\n               <jats:p>Results: The patient presented with painful cortical lesions in his leg. Radiographs of the affected bone showed diaphyseal hyperostosis. The lesional tissue comprised trabeculae of immature, woven bone surrounded by fibrous tissue. Biochemistry revealed elevated phosphate, tubular maximum rate for phosphate reabsorption per deciliter of glomerular filtrate, and 1,25-dihydroxyvitamin D levels. The patient was a compound heterozygote for two novel GALNT3 mutations. His parents and brother were heterozygous for one of the mutations and had no biochemical abnormalities. Intact FGF23 level in the patient was low normal, whereas C-terminal FGF23 was elevated, a pattern similar to TC.<\/jats:p>\n               <jats:p>Conclusion: The presence of GALNT3 mutations and elevated C-terminal, but low intact serum FGF23, levels in HHS resemble those seen in TC, suggesting that HHS and TC are different manifestations of the same disorder. The absence of biochemical abnormalities in the heterozygous individuals suggests that one normal allele is sufficient for secretion of intact FGF23.<\/jats:p>","DOI":"10.1210\/jc.2006-1825","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T03:56:49Z","timestamp":1172030209000},"page":"1943-1947","source":"Crossref","is-referenced-by-count":77,"title":["Novel GALNT3 Mutations Causing Hyperostosis-Hyperphosphatemia Syndrome Result in Low Intact Fibroblast Growth Factor 23 Concentrations"],"prefix":"10.1210","volume":"92","author":[{"given":"Shoji","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Department of Medicine (S.I., E.A.I., A.H.S., M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Guigonis","sequence":"first","affiliation":[{"name":"Department of Pediatrics (V.G., M.C., S.H., A.L.), Limoges University Teaching Hospital, 87000 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A.","family":"Imel","sequence":"first","affiliation":[{"name":"Department of Medicine (S.I., E.A.I., A.H.S., M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202"},{"name":"Department of Pediatrics (E.A.I.), Indiana University School of Medicine, Indianapolis, Indiana 46202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Me\u0301lanie","family":"Courouble","sequence":"first","affiliation":[{"name":"Department of Pediatrics (V.G., M.C., S.H., A.L.), Limoges University Teaching Hospital, 87000 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Heissat","sequence":"first","affiliation":[{"name":"Department of Pediatrics (V.G., M.C., S.H., A.L.), Limoges University Teaching Hospital, 87000 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Henley","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine (J.D.H.), Indiana University School of Medicine, Indianapolis, Indiana 46202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea H.","family":"Sorenson","sequence":"first","affiliation":[{"name":"Department of Medicine (S.I., E.A.I., A.H.S., M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Petit","sequence":"first","affiliation":[{"name":"Department of Pathology (B.P.), Limoges University Teaching Hospital, 87000 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lienhardt","sequence":"first","affiliation":[{"name":"Department of Pediatrics (V.G., M.C., S.H., A.L.), Limoges University Teaching Hospital, 87000 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Econs","sequence":"first","affiliation":[{"name":"Department of Medicine (S.I., E.A.I., A.H.S., M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202"},{"name":"Department of Medical and Molecular Genetics (M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613162976600_R1","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0022-3476(81)80013-3","article-title":"The syndrome of hyperostosis and hyperphosphatemia.","volume":"99","author":"Mikati","year":"1981","journal-title":"J Pediatr"},{"key":"2020071613162976600_R2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00109-004-0610-8","article-title":"Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders.","volume":"83","author":"Frishberg","year":"2005","journal-title":"J Mol Med"},{"key":"2020071613162976600_R3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/17453679708999037","article-title":"Chronic recurrent multifocal hyperostosis of the long bones associated with hyperphosphatemia: a case report.","volume":"68","author":"Nakamura","year":"1997","journal-title":"Acta Orthop Scand"},{"key":"2020071613162976600_R4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1542\/peds.99.5.745","article-title":"Hyperostosis with hyperphosphatemia: evidence of familial occurrence and association with tumoral calcinosis.","volume":"99","author":"Narchi","year":"1997","journal-title":"Pediatrics"},{"key":"2020071613162976600_R5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.","volume":"14","author":"Benet-Pages","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2020071613162976600_R6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jcem-60-6-1093","article-title":"Genetic transmission of tumoral calcinosis: autosomal dominant with variable clinical expressivity.","volume":"60","author":"Lyles","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613162976600_R7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10038-006-0377-6","article-title":"Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred.","volume":"51","author":"Specktor","year":"2006","journal-title":"J Hum Genet"},{"key":"2020071613162976600_R8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0002-9343(61)90131-0","article-title":"Heterotopic calcification, hyperphosphatemia and angioid streaks of the retina.","volume":"31","author":"McPhaul Jr","year":"1961","journal-title":"Am J Med"},{"key":"2020071613162976600_R9","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1210\/jc.2005-0301","article-title":"A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.","volume":"90","author":"Araya","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613162976600_R10","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1210\/jc.2004-2238","article-title":"A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.","volume":"90","author":"Larsson","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613162976600_R11","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1210\/jc.2006-0305","article-title":"The role of mutant UDP-N-acetyl-\u03b1-d-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.","volume":"91","author":"Garringer","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613162976600_R12","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2006-1247","article-title":"Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene.","volume":"91","author":"Ichikawa","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613162976600_R13","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2004-2302","article-title":"A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive.","volume":"90","author":"Ichikawa","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613162976600_R14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis.","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"key":"2020071613162976600_R15","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1074\/jbc.M602469200","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation.","volume":"281","author":"Kato","year":"2006","journal-title":"J Biol Chem"},{"key":"2020071613162976600_R16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for derivation of renal threshold phosphate concentration.","volume":"2","author":"Walton","year":"1975","journal-title":"Lancet"},{"key":"2020071613162976600_R17","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","article-title":"Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.","volume":"91","author":"Imel","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613162976600_R18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1148\/radiology.151.3.6718723","article-title":"Tumoral calcinosis, diaphysitis, and hyperphosphatemia.","volume":"151","author":"Clarke","year":"1984","journal-title":"Radiology"},{"key":"2020071613162976600_R19","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0022-3476(89)80452-4","article-title":"Hyperphosphatemia associated with cortical hyperostosis and tumoral calcinosis.","volume":"114","author":"Wilson","year":"1989","journal-title":"J Pediatr"},{"key":"2020071613162976600_R20","first-page":"816","article-title":"Elevated serum calcitriol concentrations do not fall in response to hyperphosphatemia in familial tumoral calcinosis.","volume":"139","author":"Steinherz","year":"1985","journal-title":"Am J Dis Child"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/5\/1943\/9055889\/jcem1943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/5\/1943\/9055889\/jcem1943.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T23:34:21Z","timestamp":1594942461000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/5\/1943\/2598928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-1825","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}